P-cadherin Monoclonal Antibody (12H6) - Citations

P-cadherin Monoclonal Antibody (12H6) - Citations

View additional product information for P-cadherin Monoclonal Antibody (12H6) - Citations (324000)

Showing 1 product Citations

Citations & References
Abstract
P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness.
AuthorsThuault S, Hayashi S, Lagirand-Cantaloube J, Plutoni C, Comunale F, Delattre O, Relaix F, Gauthier-Rouvière C,
JournalOncogene
PubMed ID22710718
Alveolar rhabdomyosarcoma (ARMS) is an aggressive childhood cancer of striated muscle characterized by the presence of the PAX3-FOXO1A or PAX7-FOXO1A chimeric oncogenic transcription factor. Identification of their targets is essential for understanding ARMS pathogenesis. To this aim, we analyzed transcriptomic data from rhabdomyosarcoma samples and found that P-cadherin expression is ... More